A 56-year-old man with obesity and newly diagnosed type 2 diabetes (HbA1c 8.5%) has no cardiovascular disease or chronic kidney disease. His eGFR is 80 mL/min/1.73 m². What is the most appropriate initial pharmacologic therapy according to Diabetes Canada?